Cargando…
Glucocorticoid Priming of Nonviral Gene Delivery to hMSCs Increases Transfection by Reducing Induced Stresses
Human mesenchymal stem cells (hMSCs) are under study for cell and gene therapeutics because of their immunomodulatory and regenerative properties. Safe and efficient gene delivery could increase hMSC clinical potential by enabling expression of transgenes for control over factor production, behavior...
Autores principales: | Hamann, Andrew, Kozisek, Tyler, Broad, Kelly, Pannier, Angela K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452153/ https://www.ncbi.nlm.nih.gov/pubmed/32913879 http://dx.doi.org/10.1016/j.omtm.2020.07.014 |
Ejemplares similares
-
Comparison of promoter, DNA vector, and cationic carrier for efficient transfection of hMSCs from multiple donors and tissue sources
por: Kozisek, Tyler, et al.
Publicado: (2021) -
Mechanisms of unprimed and dexamethasone‐primed nonviral gene delivery to human mesenchymal stem cells
por: Hamann, Andrew, et al.
Publicado: (2018) -
High-throughput screening of clinically approved drugs that prime nonviral gene delivery to human Mesenchymal stem cells
por: Kozisek, Tyler, et al.
Publicado: (2020) -
Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105(+) hMSCs
por: Schade, Anna, et al.
Publicado: (2014) -
IRX5 promotes adipogenesis of hMSCs by repressing glycolysis
por: Jiang, Bulin, et al.
Publicado: (2022)